Selected Grants
H5N1 Vaccine Trial - Hemagglutinin Inhibition (HAI) and Microneutralization (MN) Assays 25S-092
ResearchPrincipal Investigator · Awarded by Leidos Biomedical Research, Inc. · 2025 - 2027CIVICs C Option 16 Equitable Adjustment (EA)
ResearchInvestigator · Awarded by National Institutes of Health · 2019 - 2026CIVICs A Option 22D
ResearchInvestigator · Awarded by National Institutes of Health · 2024 - 2026CIVICs Component A Year 7 - Option 6
ResearchResearch Associate · Awarded by National Institutes of Health · 2019 - 2026SRA - Neutralization capacity of purified anti-SARS-CoV-2 monoclonal antibodies
ResearchPrincipal Investigator · Awarded by Invivyd, Inc. · 2025 - 2026Loss of cellular identify after influenza virus infection and effects on pulmonary function
ResearchAssistant Research Professor · Awarded by National Institutes of Health · 2018 - 2024The effects of cells that survive direct influenza A virus infection on lung repair
ResearchResearch Associate · Awarded by National Institutes of Health · 2017 - 2019Effect of m6A editing of RNA on influenza A virus replication
ResearchSenior Research Associate · Awarded by National Institutes of Health · 2017 - 2018Survival of influenza A virus infected cells and effects on pathogenesis
ResearchSenior Research Associate · Awarded by National Institutes of Health · 2015 - 2017External Relationships
- The University of Chicago
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.